GCM
ALXO icon

Graham Capital Management’s ALX Oncology ALXO Stock Holding History

Graham Capital Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75.7K Buy
+37,739
New +$71.9K ﹤0.01% 1069
2024
Q4 		– Sell
-96,849
Closed -$176K – 1212
2024
Q3 		$176K Buy
96,849
+72,907
+305% +$271K ﹤0.01% 940
2024
Q2 		$144K Buy
+23,942
New +$294K ﹤0.01% 902

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Graham Capital Management's ALXO Position: Q1 2026 in Review

Graham Capital Management opened a new position in ALX Oncology (ALXO) in Q1 2026: 37,739 shares worth $75.7K. The stake represents ﹤0.01% of the portfolio and ranks #1069 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in ALXO as recently as Q3 2024.

Graham Capital Management first reported a position in ALXO in Q2 2024 and has held it in 3 quarters since. The position peaked at $176K in Q3 2024. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Graham Capital Management held 37,739 shares of ALX Oncology worth $75.7K as of Q1 2026.
  • ALX Oncology was a new Graham Capital Management position in Q1 2026.
  • ALX Oncology made up ﹤0.01% of Graham Capital Management's portfolio in Q1 2026, its #1069 holding.
  • Graham Capital Management first reported a position in ALX Oncology in Q2 2024 and has held it in 3 quarters since.
  • Graham Capital Management's ALX Oncology position peaked at $176K in Q3 2024.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.